BioCina

One of BioCina’s clients, GPN Vaccines, brought its novel life saving pneumococcal vaccine to clinical trials by working with BioCina. This vaccine has the potential to save up to two million lives each year. BioCina provided them with a robust and reproducible manufacturing process and a clinical batch of vaccine substance in just ten months — exceeding GPN’s timeline requirements.    Read the full case study here 👉 https://lnkd.in/gdFrjR2Z Ready to scale-up your science? Let’s partner up! 🤝 Contact us today. #CDMO #biologics #microbial #pDNA #mRNA

Elite Quality at Every Step! Quality is a culture at BioCina. It is core to every aspect of all of our services.  We offer services in compliance with regulations and guidelines from the most stringent regulatory authorities. We provide a phase appropriate quality approach that earns the trust of our clients through all phases of our client programs, comprising of clinical trials, validation studies and product approvals.    Learn more here 👉 https://lnkd.in/gEvgCNV2 

At BioCina, we specialise in cGMP clinical and commercial manufacturing across a spectrum of modalities, including #microbial, #pDNA, and #mRNA.  We deliver on-time and in-full for our clients every step of the way from idea to end product. We’re always inspection-ready and provide unmatched service with all the intangibles that make our client relationships stand the test of time.   See why BioCina is the choice for an elevated biologics manufacturing experience 👇  

As a premium provider of Contract Development and Manufacturing Organization (#CDMO) services for #biologics located in #Australia, BioCina is at the vanguard of a new wave of therapeutic process development and manufacturing services. Based in Adelaide, South Australia, BioCina is the only US FDA-approved #microbial drug substance facility of its kind in Australia.  Reach out to one of our Business Development team members to learn more about how you can benefit from working with an Australia-based CDMO for your biologic manufacturing needs. Jan Bekker (for US-based companies), Ryan Parlett (for APAC and Europe-based companies), Alex Pomerantz (for US-based companies) 

For fans and followers of the Molecule to Market podcast, I have a real treat for you. I recently interviewed Mark W. Womack, Chief Executive Officer at BioCina based in awesome Adelaide, Australia My guest talks openly about how his tough upbringing in LA led him to the US Navy, and then onto a pathway into senior leadership in the biopharma CDMO space. Mark also shares his views on how in reality, most biologics CDMOs frequently fail to deliver for clients. And why winning in this game requires operating with discipline, and consistently executing at a high level. Listen, enjoy, rate and share... wherever you get your podcast fix 😊 🎧 Apple:  https://lnkd.in/dvqDVGBe 🎧 Amazon: https://lnkd.in/dTtaTniS 🎧 Spotify: https://lnkd.in/d7Jiq-Hn

A rewarding way to end the week as BioCina hosted our Biggest Morning Tea event this morning in support of Cancer Council Australia. 🍰 ☕ With nearly 1 in 2 Australians diagnosed with cancer before age 85, we’re committed to making a change. Every dollar raised makes a significant impact on those impacted by cancer and help fund vital cancer research, support services and prevention programs. We smashed our $500 goal and raised a total of $1102.00!!! 🙌 🎉 A big thank you to everyone who participated and for donating their time, money and tea-riffic cooking talents to such a great cause.   #CancerCouncilAustralia #Biggestmorningtea  

I finally got out to see some of the booths at #BIO24. Here are a couple of my favourites… BioCina and Avance Clinical #southaustralia Mark W. Womack | Yvonne Lungershausen

Our Business Development team has arrived at the BIO International Convention in San Diego! 👋   We’re looking forward to connecting with our current and future partners over the next few days at BIO.  Find us at Booth #5923 or reach out to our attending team Mark W. Womack, Jan Bekker, Alex Pomerantz, Ryan Parlett to learn more about BioCina’s innovative offerings for development and manufacturing of #microbial, #pdna, and #mrna products.          #CDMO #biologics #BIO2024 #BIOInternationalConvention #BioCina 

📢 PR Release: BioCina Acquires the Exclusive #CDMO Rights for Leading-Edge #Minicircle #DNA Technology Platform from CelluTx We are excited to announce the exclusive rights to utilize CelluTx’s Recombination Based Plasmid System (RBPS) technology with BioCina’s CDMO clients. Our Chief Executive Officer, Mark W. Womack stated, “We are pleased to announce our partnership with CelluTx enabling BioCina to exclusively provide this innovative technology to our clients around the world. We have already witnessed great success in utilizing it within our client portfolio and eagerly anticipate advancing many other client programs with the technology.” For more information please see the full press release here 👉 https://lnkd.in/g6ScC-9Q

Join us as Excellence meets Innovation at BioCina. Embark on Mark W. Womack's remarkable journey from the US Navy to leading great companies in the biopharmaceutical industry. In a gripping podcast, Mark shares insights on disciplined execution, a no excuses mentality to overcoming challenges and building high-performance, client-centric organisations, while highlighting BioCina's ambitious plans for the future. Inspired by his single mother's resilience, Mark's personal story adds depth to his visionary leadership in biotech. 🎧 Listen here: https://lnkd.in/gQ3Xd4PE Interested in a specific topic? Jump to it! 1. Mark W. Womack's Career Journey • 00:00:42 2. Transition to BioCina in Australia • 00:17:25 3. Meeting Challenges in the CDMO Space • 00:27:19 4. Customer-Centric Culture at BioCina • 00:33:02 5. Building a Vision-Aligned Management Team • 0:34:17 6. Impact of Global Macroeconomics on the Biologics Industry • 0:36:01 7. Future Plans for BioCina • 0:38:37 8. Personal Journey and Motivation • 0:42:38 9. Tribute to Mark's Mother • 0:44:48 Molecule to Market Raman Sehgal #BiotechLeader #Innovation #BioCina #BiologicsCDMO #microbial #pDNA #mRNA #moleculetomarket #podcast #pharmapodcast #lifesciences #pharmaceuticals